Global Kinase Inhibitors Market Revenue (US$ Mn), by Protein Kinase C Inhibitors, 2020-2034 Figure 08: Global Kinase Inhibitors Market Revenue (US$ Mn), by RHO Kinase Inhibitors, 2020-2034 Figure 09: ...

Inhibition of nonsense-mediated decay turns immunologically cold tumors hot by increasing the amount of mutant RNA leading to an increase in T-cell-targetable neoantigens on the cell surface.

This content introduces the physiological and pathological importance of protein kinases, kinase inhibitors approved for ...

Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...

Clinical research suggests that combining a novel agent called navtemadlin with DNA-damaging chemotherapy for the treatment of glioblastoma, a form of brain cancer, could increase efficacy.

Alpha-synuclein inhibitors are a class of investigational therapies targeting the pathological aggregation of alpha-synuclein, a protein implicated i ...

The new study adds to growing evidence that measuring activated proteins is key to cancer therapy selection. Golden, CO, Feb.

Palbociclib, a well-tolerated and selective CDK4/6 inhibitor, has shown promising results in the treatment of retinoblastoma ... resistance to palbociclib were assessed in human liver cancer cell ...

an oral small molecule inhibitor of the MDM2-p53 protein-protein interactions to treat solid tumors and hematological malignancies; and APG-1252, a small molecule drug to restore apoptosis through ...

State of New Jersey Common Pension Fund D boosted its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by ...